Inhibitory activities of quinolones against DNA gyrase of Chlamydia pneumoniae

被引：21

作者：

Ameyama, S ^{[1
]}

Shinmura, Y ^{[1
]}

Takahata, M ^{[1
]}

机构：

[1] Toyama Chem Co Ltd, Res Labs, Toyama 9308508, Japan

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2003年 / 47卷 / 07期

关键词：

D O I：

10.1128/AAC.47.7.2327-2329.2003

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

The gyrA and gyrB genes of Chlamydia pneumoniae TW-183 were cloned, and their proteins were purified by use of a fusion system with a maltose-binding protein. The 50% inhibitory concentrations of garenoxacin, sparfloxacin, moxifloxacin, gatifloxacin, and levofloxacin were 10.1, 47.5, 39.6, 64.2, and 156.9 mug/ml, respectively, and the MICs against C. pneumoniae TW-183 were 0.008, 0.016, 0.063, 0.125, and 0.25 mug/ml, respectively.

引用

页码：2327 / 2329

页数：3

共 50 条

[1] Inhibitory activities of quinolones against DNA gyrase and topoisomerase IV of Enterococcus faecalis
Onodera, Y
Okuda, J
Tanaka, M
Sato, K
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (06) : 1800 - 1804
[2] Inhibitory activity of quinolones against DNA gyrase of Mycobacterium tuberculosis
Onodera, Y
Tanaka, M
Sato, K
[J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 47 (04) : 447 - 450
[3] Inhibitory activities of quinolones against DNA gyrase and topoisomerase IV purified from Staphylococcus aureus
Tanaka, M
Onodera, Y
Uchida, Y
Sato, K
Hayakawa, I
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (11) : 2362 - 2366
[4] INVITRO ACTIVITIES OF 5 QUINOLONES AGAINST CHLAMYDIA-PNEUMONIAE
HAMMERSCHLAG, MR
HYMAN, CL
ROBLIN, PM
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (03) : 682 - 683
[5] Activity of Quinolones Against Chlamydia pneumoniae
Margaret R. Hammerschlag
[J]. Drugs, 1999, 58 : 78 - 81
[6] Activity of quinolones against Chlamydia pneumoniae
Hammerschlag, MR
[J]. DRUGS, 1999, 58 (Suppl 2) : 78 - 81
[7] Inhibitory activity of garenoxacin against DNA gyrase of Mycoplasma pneumoniae
Nakatani, Masatoshi
Mizunaga, Shingo
Takahata, Masahiro
Nomura, Nobuhiko
[J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2012, 67 (08) : 1850 - 1852
[8] In Vitro Activity of AZD0914, a Novel DNA Gyrase Inhibitor, against Chlamydia trachomatis and Chlamydia pneumoniae
Kohlhoff, Stephan A.
Huband, Michael D.
Hammerschlag, Margaret R.
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (12) : 7595 - 7596
[9] Targeting of DNA gyrase in Streptococcus pneumoniae by sparfloxacin: Selective targeting of gyrase or topoisomerase IV by quinolones
Pan, XS
Fisher, LM
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (02) : 471 - 474
[10] DISCREPANCY BETWEEN THE ANTIBACTERIAL ACTIVITIES AND THE INHIBITORY EFFECTS ON MICROCOCCUS-LUTEUS DNA GYRASE OF 13 QUINOLONES
FU, KP
GRACE, ME
MCCLOUD, SJ
GREGORY, FJ
HUNG, PP
[J]. CHEMOTHERAPY, 1986, 32 (06) : 494 - 498

← 1 2 3 4 5 →